Real-time enrollment status for this primary immunodeficiency diseases clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:17 AM UTC
| NCT Number | NCT04640142 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Primary Immunodeficiency Diseases |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Octapharma |
| Last Updated on CT.gov | October 3, 2025 (Oct 3, 2025) |
As of March 2, 2026: Clinical trial NCT04640142 is currently active_not_recruiting participants. This clinical trial study for primary immunodeficiency diseases is not currently accepting new participants at 11 locations across the United States. The study is sponsored by Octapharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04640142 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04640142 was last updated Oct 3, 2025 (October 3, 2025). HelloStudys verifies this status automatically.